Skip to main content


OCPC 2022
The Official Partner of the Oncology Clinical Pathways Congress
Utilizing Clinical Pathways to Improve the Quality of Cancer Care.
Welcome Back to Boston

Registration is now open for the 2022 in-person Congress taking place October 14-16. The landscape of cancer care is rapidly evolving and oncology pathways play a critical role in defining how we treat our patients. We are excited to be back in Boston for an informative and substantive three-day program. 

As the official congress of the Journal of Clinical Pathways, this meeting serves as a forum for those involved in all stages of the pathway development to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway programs.

What to Expect

The Oncology Clinical Pathways Congress is a one-of-a-kind opportunity for all of those in cancer care to gather together and make a positive impact on the future of patient care.


    Leading Cancer Organizations
    Expert Presenters
    Unmatched Educational Sessions
    Meet the Steering Committee
    Robin T. Zon, MD, FACP, FASCO
    Past Chair, ASCO Pathways Task Force
    Physician Emeritus, Finance & Quality Chair
    Michiana Hematology-Oncology, PC
    Mishawaka, Indiana
    Alan Balch, PhD
    Chief Executive Officer
    Patient Advocate Foundation
    National Patient Advocate Foundation
    Hampton, Virginia
    Wui-Jin Koh, MD
    Senior Vice President, Chief Medical Officer
    National Comprehensive Cancer Network
    Ft. Washington, Pennsylvania
    Frederick M. Schnell, MD, FACP
    Chief Medical Officer
    National Cancer Treatment Alliance/Community Oncology Alliance
    Washington, DC
    Stephen B. Edge, MD, FACS, FASCO
    Vice President, Healthcare Outcomes & Policy, Professor of Surgery and Oncology, Department of Surgical Oncology, Breast Service, Roswell Park Comprehensive Cancer Center, Professor of Surgery, Jacobs School of Medicine, University at Buffalo
    Buffalo, New York
    Mahek A. Shah, MD, MBA, MS
    Physician Executive, Investor, and Advisor
    Harvard Business School
    Associate Faculty
    Harvard School of Public Health and Brigham Health, Ariadne Labs
    Boston, Massachusetts
    Network With Pathway Pioneers

    This is your chance to learn best practices and common pitfalls from those who have experienced the sourcing, design, implementation, and evaluation process through:

    • Case-Based Presentations
    • Roundtable Discussions
    • Networking Activities

    Who Should Attend?

    This program is designed for healthcare professionals interested in learning how to implement, maintain, and measure treatment pathways.

    Cancer Center Directors
    Directors of Oncology Practice Programs
    Oncologist & Hematologists
    Pathway Development Executives
    Commercial & Government Payers
    Reimbursement Specialists
    Specialty Pharmacists
    HEOR Specialists
    Nurse Navigators
    Students, Residents & Fellows
    I think this is the best conference of its kind as it relates to clinical pathways on the road to value-based care."

    Dr. Frederick Schnell
    Chief Medical Officer
    Community Oncology Alliance

    This meeting is a great place for clinicians to be interactive with their peers and to learn about the latest advances in not only pathways and their development but also how they're used in a practice setting."

    Gordon Kuntz

    A ‘cookie cutter’ approach to cancer care will impede our ability to personalize care and meet patient needs. Pathways need to demonstrate flexibility to capitalize on advances in medical treatment, reflect development with scientific evidence, and assure providers that they offer the best possible outcomes for the patient."

    Robin Zon, MD, FACP, FASCO
    Chair, ASCO Pathways Task Force

    Keep Me Informed